NTT FY Profit Increases

Nippon Telegraph and Telephone Corp (NTT) reported that its profit attributable to the company for the year ended March 31, 2021 increased to 916.18 billion yen or 248.15 yen per share from 855.31 billion yen or 231.21 yen per share in the previous year.

Operating revenues for the year grew to 11.94 trillion yen from 11.90 trillion yen last year.

For the fiscal year ending March 31, 2022, the company projects basic earnings per share of 300 yen; and operating revenue of 12.00 trillion yen.

NTT Corp. said that it will establish a new Israeli subsidiary named, " NTT Innovation Laboratory Israel Ltd" In July 2021.

NTT announced that the Board of Directors meeting held Wednesday resolved the followings. There is no change in the members.These executive positions will be approved officially at the board of directors meeting, scheduled to be held on June 24, 2021.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Mallinckrodt plc announced Wednesday that the U.S. Food and Drug Administration or FDA has approved StrataGraft (allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen - dsat) for the treatment of adult patients with thermal burns containing intact dermal elements for which surgical intervention is clinically indicated. Worldwide 5G mobile subscriptions are estimated to exceed 580 million by the end of 2021, according to the Ericsson Mobility Report. With subscriptions increasing at a rate of about a million per day, 5G remains on track to become the fastest adopted mobile generation in history. The growth in subscriptions is being lead by China, North America and the Gulf Cooperation Council markets. Elanco Animal Health Inc. (ELAN) and veterinary biopharmaceutical company Kindred Biosciences, Inc. (KIN) announced Wednesday they have entered into a definitive agreement for Elanco to acquire Kindred for $9.25 per share, or approximately $440 million. The acquisition further accelerates Elanco's...
Follow RTT